Psyched Wellness Provides Corporate Update Jun 10, 2026 05:15PM
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector Apr 23, 2026 07:30AM
Psyched Wellness completes C$859,653 private placement and debt settlement Mar 20, 2026 09:17AM
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director Mar 20, 2026 09:16AM
Psyched Wellness announces private placement for up to C$1.7 million Mar 11, 2026 08:56AM


Mar 11, 2026 08:54AM Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94
Jan 15, 2026 12:42PM Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run
Nov 27, 2025 07:30AM Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Oct 9, 2025 07:30AM Psyched Wellness Provides Comprehensive Investor Update
Apr 10, 2025 07:30AM Psyched Wellness Provides Comprehensive Investor Update
Mar 14, 2025 07:30AM Psyched Wellness Provides Comprehensive Investor Update
Nov 25, 2024 07:30AM Psyched Wellness Announces Appointment of New Director and Resignation of a Director
Aug 6, 2024 04:44PM Psyched Wellness Announces Supply Chain Disruption in the US
Jul 17, 2024 09:10AM Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer
Jun 13, 2024 07:30AM Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA